Compare Axogen Inc (AXGN) vs Firy Inc. (FIRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Firy Inc. — how do they compare? Axogen Inc trades at $34.62 (market cap $2.03B), while Firy Inc. trades at $11.48 (market cap $190.82M). The key difference: Axogen Inc is far larger — about 10.6× Firy Inc.'s market cap, and Firy Inc. is trading nearer its 52-week high, Axogen Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Axogen Inc for 18 Days and Firy Inc. for 13 Days on average.
| AXGN | FIRY | |
|---|---|---|
Market Cap | $2.03B | $190.82M |
Volume | 1,127,465 | 111,656 |
Sector | Health | Technology |
52-Week High | $51.73 | $13.10 |
52-Week Low | $16.59 | $2.28 |
Typical Hold Time | 18 Days | 13 Days |
Enterprise Value | $1.94B | $159.42M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Axogen (AXGN) trades at $34.62, down 2.83% on the day amid a bearish technical signal. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million but missed earnings expectations. Recent developments include the $200 million acquisition of BioCircuit Technologies and a $208.7 million public offering to fund expansion. Gross margins remain strong at 74.56%, but net income is negative with a -13.36% margin.
Analyst consensus is strongly bullish with a $53.17 price target, representing significant upside potential. Key risks include execution of the acquisition, integration costs, and ongoing profitability challenges. The stock's current valuation metrics suggest growth expectations are priced in, making earnings delivery critical for sustained momentum.
FIRY (formerly Skillz Inc.) trades at $11.48, down 0.78% with a bearish technical signal. The company shows persistent financial challenges with negative net income margins (-60.23%) and cash burn, though revenue stabilized at $104.50M in 2025. Recent developments include a $719M legal victory and board additions, but earnings misses and negative ROE (-62.95%) highlight operational struggles.
The outlook remains cautious with significant execution risks despite potential from legal wins. Analyst consensus is mixed (20% Buy, 60% Hold) reflecting uncertainty about cash flow sustainability and profitability timeline. Investment opportunity hinges on successful monetization of legal awards and operational turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Firy Inc.
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →
